These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1390493)

  • 1. The role of preservatives in the conjunctival toxicity of subconjunctival gentamicin injection.
    Pande M; Ghanchi F
    Br J Ophthalmol; 1992 Apr; 76(4):235-7. PubMed ID: 1390493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postoperative conjunctival chemosis in cataract surgery caused by subconjunctival gentamicin injection.
    Pande M
    Br J Ophthalmol; 1991 Nov; 75(11):660-2. PubMed ID: 1751459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised single blind trial to compare the toxicity of subconjunctival gentamicin and cefuroxime in cataract surgery.
    Jenkins CD; McDonnell PJ; Spalton DJ
    Br J Ophthalmol; 1990 Dec; 74(12):734-8. PubMed ID: 2275936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of povidone-iodine drop instead of sub-conjunctival injection of dexamethasone and gentamicin combination at the end of phacoemulsification cataract surgery.
    Ahmed MS; Moly KN; Aziz MA
    Mymensingh Med J; 2010 Apr; 19(2):232-5. PubMed ID: 20395917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular toxicity of subconjunctival gentamicin.
    Green K; Chapman J; Cheeks L
    Lens Eye Toxic Res; 1992; 9(3-4):439-46. PubMed ID: 1301796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of a collagen corneal shield and a subconjunctival injection at the end of cataract surgery.
    Renard G; Bennani N; Lutaj P; Richard C; Trinquand C
    J Cataract Refract Surg; 1993 Jan; 19(1):48-51. PubMed ID: 8426322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early conjunctival changes following treatment with metipranolol and preservatives are not reversible with dexamethasone.
    Mietz H; Schlötzer-Schrehardt U; Lemke JH; Krieglstein GK
    Graefes Arch Clin Exp Ophthalmol; 1997 Jul; 235(7):452-9. PubMed ID: 9248843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Necrotizing conjunctival ulceration following subconjunctival depot methylprednisolone injection.
    Zamir E; Pe'er J
    Ophthalmic Surg Lasers; 1999; 30(7):565-6. PubMed ID: 10929981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent].
    Mlčáková E; Mlčák P; Karhanová M; Langová K; Marešová K
    Cesk Slov Oftalmol; 2016; 72(4):120-127. PubMed ID: 27860477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzalkonium chloride induces subconjunctival fibrosis through the COX-2-modulated activation of a TGF-β1/Smad3 signaling pathway.
    Huang C; Wang H; Pan J; Zhou D; Chen W; Li W; Chen Y; Liu Z
    Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8111-22. PubMed ID: 25406285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
    Maca SM; Amon M; Findl O; Kahraman G; Barisani-Asenbauer T
    Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of prophylactic, topical and subconjunctival treatment in cataract surgery.
    Sanders R; MacEwen CJ; Haining WM
    Eye (Lond); 1992; 6 ( Pt 1)():105-10. PubMed ID: 1426392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Is subconjunctival steroid administration in addition to local therapy after cataract operations necessary? A laser tyndallometric study].
    Schmitt K; Hessemer V
    Ophthalmologe; 1995 Jun; 92(3):303-6. PubMed ID: 7655203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
    Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino M; Puska P; Palmgren E; Hamacher T; Hofmann G; Petzold G; Richter U; Riedel T; Winter M; Ropo A
    Acta Ophthalmol; 2010 May; 88(3):329-36. PubMed ID: 20546237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRESERVATIVES FROM THE EYE DROPS AND THE OCULAR SURFACE.
    Coroi MC; Bungau S; Tit M
    Rom J Ophthalmol; 2015; 59(1):2-5. PubMed ID: 27373107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxic anterior segment syndrome after cataract surgery secondary to subconjunctival gentamicin.
    Litwin AS; Pimenides D
    J Cataract Refract Surg; 2012 Dec; 38(12):2196-7. PubMed ID: 23195258
    [No Abstract]   [Full Text] [Related]  

  • 17. [Managing treatment side effects: the respective roles of the active ingredient and the preservative].
    Aptel F; Denis P; Baudouin C
    J Fr Ophtalmol; 2011 Jun; 34(6):409-12. PubMed ID: 21511364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of preservatives in anti-glaucoma agents on the ocular surface].
    Potop V
    Oftalmologia; 2009; 53(2):92-6. PubMed ID: 19697847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal orbital irritant contact dermatitis caused by gentamicin ointment.
    Merlob P; Metzker A
    Cutis; 1996 Jun; 57(6):429-30. PubMed ID: 8804846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bulbar conjunctival defects associated with gentamicin.
    Nauheim R; Nauheim J
    Arch Ophthalmol; 1987 Oct; 105(10):1321. PubMed ID: 3662899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.